There are 128 resources available
Translating cancer genetics into medicines and disease insights
Presenter: David Adams
Session: Future needs and techniques in oncology research
Resources:
Slides
Webcast
Controversies in the surgical management of stage III melanoma
Presenter: Merrick Ross
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
Resources:
Slides
Webcast
Adjuvant and neo-adjuvant therapy
Presenter: Georgina Long
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
Resources:
Slides
Webcast
Translational research: Ready for patient selection?
Presenter: Christian Blank
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Zuhir Bodalal
Session: Future needs and techniques in oncology research
Resources:
Webcast
Q&A and live discussion
Presenter: Christian Blank
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
Resources:
Webcast
The clinical perspective: Trials fit for purpose in 2020 and beyond
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The regulatory perspective: How to look for certainty in terra incognita
Presenter: Francesco Pignatti
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The HTA perspective: Is tissue-independent approval the next top model?
Presenter: Sonia Garcia Perez
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Implementation of NGS diagnostics in the NHS: The example of Belgium
Presenter: Marc Van Den Bulcke
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast